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Background: In order to understand the molecular epidemiology of severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) in Sri Lanka, since March 2020, we
carried out genomic sequencing overlaid on available epidemiological data until April
2021.
Methods: Whole genome sequencing was carried out on diagnostic sputum or
nasopharyngeal swabs from 373 patients with COVID-19. Molecular clock phylogenetic
analysis was undertaken to further explore dominant lineages.
Results: The B.1.411 lineage was most prevalent, which was established in Sri Lanka
and caused outbreaks throughout the country until March 2021. The estimated time
of the most recent common ancestor (tMRCA) of this lineage was June 1, 2020 (with
95% lower and upper bounds March 30 to July 27) suggesting cryptic transmission
may have occurred, prior to a large epidemic starting in October 2020. Returning
travellers were identified with infections caused by lineage B.1.258, as well as the more
transmissible B.1.1.7 lineage, which has replaced B.1.411 to fuel the ongoing large
outbreak in the country.
Conclusions: The large outbreak that started in early October, is due to spread of a
single virus lineage, B.1.411 until the end of March 2021, when B.1.1.7 emerged and
became the dominant lineage.
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INTRODUCTION
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged as the leading
cause of mortality in several countries in the world. As of May 24, 2021, 167 million cases
and 3.45 million deaths have been reported worldwide (John Hopkins University, 2021). Due to
the emergence of variants of concern, the World Health Organization has recommended whole
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genomic sequencing of the SARS-CoV-2 viruses within countries
regularly and systematically for early identification of such
variants (World Health Organization, 2021).
The first patient infected with SARS-CoV-2 in Sri Lanka
was reported on the January 27, 2020, who was a foreign
national, with the first Sri Lankan patient reported on the of
March 10, 2020 (Ministry of Health, 2020a). In the following
6 months (March–September), the spread of the virus was largely
contained with only 3,111 reported cases, of which 38.8% were
imported (Ministry of Health, 2020b). However, there was a
surge in the number of cases with discovery of a new cluster
in early October 2020 in a clothing factory in the district
adjacent to Colombo (Gampaha). This was followed by rapid
spread of SARS-CoV-2 within the Colombo Municipality region
(CMC), fish markets and subsequently to the whole country. This
outbreak continued to evolve, with infections being reported in
all regions of the country, but the numbers gradually declined
by end of March 2021, with the number of daily cases been
reported falling to 200–300 cases per day (Ministry of Health,
2021a). The number of daily cases remained <250 cases/day
until mild-April 2021, when a gradual and steep rise in the
number of cases was seen with daily infections rising over
1,000/day by the last week of April to over 2,500/day by mid-May
(Ministry of Health, 2021b).
We carried out SARS-CoV-2 sequencing from isolates
collected throughout the different phases of the pandemic
in order to determine the molecular epidemiology of SARS-
CoV-2 in Sri Lanka, including current circulation of viruses
with mutations that may confer greater transmissibility and/or
threaten the efficacy of vaccines.
MATERIALS AND METHODS
Patients
Initial real-time quantitative PCR (RT-PCR) of diagnostic
sputum or nasopharyngeal swabs were carried out using TaqPath
COVID-19 CE-IVD RT-PCR kit (Thermo Fisher Scientific,
United States) according to the manufacturer’s instructions.
373 positive samples with cycle threshold (Ct) values <30 was
directed to whole genome sequencing. Ethical approval for the
study was obtained by the Ethics Review Committee of the
University of Sri Jayewardenepura.
Viral RNA Extraction
Viral RNA was extracted using QIAamp viral RNA mini
kit (Qiagen, United States), SpinStarTM Viral Nucleic Acid
Extraction kit 1.0 (ADT Biotech, Malaysia) or FastGene
RNA Viral Kit (Nippon Genetics, Germany), according
to manufacturer’s instructions. Presence of ORF1ab gene
and N gene of SARS-CoV-2 was detected with Novel
Coronavirus (2019-Ncov) Nucleic Acid Diagnostic Kit (Sansure
Biotech) and S gene was detected by Taqpath COVID-19
RT PCR kit (Applied Biosystems) by real time RT PCR
in ABI 7500 real time PCR system (Applied Biosystems,
United States).
Library Preparation and Next Generation
Sequencing
Library preparation was attempted using either the TruSeq
Stranded Total RNA Library Prep Gold (Illumina, San Diego,
CA, United States) or The AmpliSeq for Illumina SARS-CoV-2
Community Panel, in combination with AmpliSeq for Illumina
library prep, index, and accessories (Illumina, San Diego, CA,
United States). Shotgun metagenomic sequencing workflow
was used for four initial samples, while for the remainder
(n = 369) a targeted RNA/cDNA amplicon assay was used
(Supplementary Methods).
Phylogenetic Analysis of Severe Acute
Respiratory Syndrome Coronavirus-2
Sequences
Sequences (n = 373) with ≥10× median read depth and
≥86% genome coverage were taken forward for further analysis.
Their GISAID accession numbers, location, and the clades of
sequences used are shown in Supplementary Table 1. The 373
Sri Lanka sequences were combined with 3,200 representative
global sequences to evaluate the phylogenetic relationships of
the viruses circulating in Sri Lanka in relation to the global
phylogenetic population. The representative sample of global
sequences was obtained in two steps using all available data on
GISAID up until May 12, 2021. The first step included randomly
selecting one sequence per country per epidemiological week
(week 0 refers to December 22–28, 2019, when the first Wuhan
genome was collected). This was then followed by a random
sampling of the remaining sequences to generate a sample of
3,200 sequences. All sequences were then aligned to the SARS-
CoV-2 reference strain MN908947.3 using MAFFT version 7.477
(Katoh et al., 2002). We masked alignment positions that have
been previously flagged as problematic1 and manually removed
obvious sequencing errors and potential homoplasic positions.
A maximum likelihood tree was constructed using IQ-TREE2
version 2.1.2 (Minh et al., 2020). Following Rambaut et al. (2020)
the IQ-TREE2 analysis was performed using the GTR+G model
of nucleotide substitution (Tavaré, 1986; Yang, 1994) and 1,000
replicates of ultrafast bootstrapping (−B 1000) and SH-aLRT
branch test (−alrt 1000).
The time-scaled phylogeny was undertaken to estimate the
emergence time of B.1.411 and the introduction time of B.1.1.7
in Sri Lanka. The time-scale phylogeny were reconstructed using
both a Bayesian approach (BEAST) and a maximum likelihood-
based method (Sagulenko et al., 2018). The analyses were
performed using sequences from Sri Lanka only. The alignment
andmaximum likelihood tree construction were performed using
MAFFT and IQ-TREE2 as described above. TempEst (v1.5.3)
(Rambaut et al., 2016) was used to examine the temporal signal of
the sequences, as well as to identify outlier sequences in the tree.
18 sequences were strong outlier and removed from the analysis,
leaving a total of 355 sequences in the final dataset. Repeating the
above steps, we confirmed that there was a strong temporal signal
in the final dataset with R2 of 0.49 and correlation coefficient of
1https://github.com/W-L/ProblematicSites_SARS-CoV-2
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0.70 (using the correlation best-fitting root function). No further
outliers were identified from the final dataset.
Using a BEAST implemented in BEAST v1.10.4 (Suchard et al.,
2018), time-scaled phylogenetic reconstruction was performed
to estimate the timing and the spread of SARS-CoV-2 viruses
in Sri Lanka. The HKY model was used to model nucleotide
evolution (Hasegawa et al., 1985) with a relaxed molecular
clock. Following the previous estimation by Duchene et al.
(2020), the initial evolutionary clock rate was set to 0.001
substitutions per site per year. An exponential growth coalescent
tree prior was used to account for the characteristics of
early stages of SARS-CoV-2 outbreak (Fountain-Jones et al.,
2020; Volz et al., 2021a). The BEAST analysis was ran
with the MCMC chain length of 40 million and sampling
frequency of 2000. Convergence was assessed using Tracer
(Rambaut et al., 2018). All model parameters had effective
sample size (ESS) values >200, confirming sufficient mixing
and convergence to stationary. The maximum clade credibility
tree was generated using TreeAnnotator (v1.10.4), with 20%
removed as burn-in. The molecular clock phylogeny was also
inferred using a maximum likelihood-based method TreeTime
(Sagulenko et al., 2018), shown in Supplementary Figure 2.
Visualisation of the phylogenetic trees were produced in R
(v4.0.1), using ggtree package. Lineages were assigned using
Pangolin (version v2.4.2, lineages version 2021-04-28). Code to
reproduce the BEAST analysis is provided in Supplementary
File 2. R code to reproduce the tree visualisation is provided in
Supplementary File 3.
Two proportional symbol maps of Sri Lanka were plotted
with GPS coordinates of the sampling locations of B.1.411 and
B.1.17 sequences using R (v4.0.1). Each sampling location was
indicated by a coloured bubble proportionate to the number of
sequences sampled within. Colombo district was zoomed into
a sub map (longitude: 79.80–79.98, latitude: 6.80–6.98) in order
to visualize the suburbs as Colombo had the highest sampling
density. R code to reproduce the map visualisation is provided
in Supplementary File 4.
RESULTS
Of six samples collected in March 2020 from returning travellers
and their contacts (period A, Figure 1: four from Colombo
district, two from Kalutara district), two belonged to lineage
FIGURE 1 | Epidemiological curves of COVID-19 cases and deaths reported in Sri Lanka from March 11, 2020 to May 22, 2021. (Data from Epidemiology Unit,
Ministry of Health, Sri Lanka) (Ministry of Health, 2020a). A, initial outbreak from overseas returned; B, closed outbreak in a the Colombo Municipality area; C,
returnees from Middle East; D, outbreak at the drug rehabilitation centre; E, the large outbreak that initially began in a clothing factory; and F, the current ongoing
outbreak.
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B.4, two to B 1.1, one to B.1 and one to B (Figure 2 and
Supplementary Table 1). During early April, SARS-CoV-2
spread within closed community clusters in the CMC region
(period B, Figure 1). Two viruses from these clusters belonged
to lineages B.4 and B.1 (Supplementary Table 1). Period C
in Figure 1 was thought to be due to an outbreak initiated
by the returning workforce from the Middle East. A sequence
was obtained from only one virus, which belonged to lineage
B. Again, due to detection of infected patients at the airport
and mandatory quarantine of all individuals for at least 14
days, during May to June, cases appeared not to spill over
to the community. However, there was a sudden surge in
the number of cases in mid-July in a drug rehabilitation
centre (DRC), in the North Central Province (period D,
Figure 1). The origin of this outbreak was not known and three
lineage B.1 sequences obtained, formed a cluster separate from
earlier B.1 sequences from Sri Lanka. This outbreak was also
subsequently controlled.
Sri Lanka then had a period of approximately 2 months during
August and September, where no locally acquired infections
were reported (Ministry of Health, 2020a). In early October, an
outbreak occurred in a clothing factory that heralded a wave
of infections, which continued to the end of March 2021. This
outbreak in early October was soon followed by widespread
transmission in many factories, fish markets island wide, in the
highly populated CMC region in Colombo and subsequently to
many areas in the country (period E, Figure 1). Following a
period of intense spread in the CMC for 4 months, the number
of cases gradually declined from January 2021 to early April 2021.
However, a rapid rise in the number of cases were seen frommid-
April 2021 (period F, Figure 1), with the numbers exponentially
increasing as of May 24, 2021.
Outbreak With the B.1.411 Lineage
We sequenced 361 samples taken during October 2020 to April
30, 2021, to determine how the outbreak evolved and establish if
there were any new introductions to fuel ongoing infections. 231
of these 361 viruses were classified into a novel lineage B.1.411.
The global phylogenetic tree shown in Figure 3 suggests that the
B.1.411 viruses are distinct from other global sequences and was
predominantly seen in Sri Lanka. This lineage was responsible
for the period E outbreak (October 2020 to early April 2021) in
Sri Lanka (Figure 2). A Bayesian time-scale phylogeny produced
using BEAST (Figure 4) suggests that the estimated time of the
FIGURE 2 | Sri Lanka sequence lineage distribution since the detection of SARS-CoV-2 in Sri Lanka. Lineage breakdown of 373 Sri Lanka samples across time.
B.1.411 was first detected in week 39 in 2020 and since B.1.411 has dominated the outbreak in Sri Lanka until week 12, 2021. B.1.1.7 was detected at the
beginning of 2021 and its prevalence has rapidly increased in Sri Lanka.
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FIGURE 3 | Phylogenetic analysis of Sri Lankan sequences. Maximum likelihood tree of 373 Sri Lanka samples and 3,200 representative global sequences obtained
from GISAID. Tips are coloured by Pango lineages, and the external layer on the right indicates the outbreak period associated with each Sri Lanka sample. The tree
was estimated using IQTree2 (GTR maximum likelihood model and +G heterogeneity rate) and 1,000 replicates of ultrafast bootstrapping (−B 1000) and SH-aLRT
branch test (−alrt 1000).
most recent common ancestor (tMRCA) of the B.1.411 lineage is
around June 1, 2020 (with 95% lower and upper bounds March
30 to July 27). A Maximum-likelihood method, TreeTime, also
estimated a similar tMRCA of June 29, 2020 (with 95% lower
and upper bounds May 23–July 30), shown in Supplementary
Figure 2. The distribution of B.1.411 cases throughout the
country is shown in Figure 5.
The predominant mutations in the spike protein were D614G
seen in 228/231 sequences and H1159Ymutation seen in 215/231
sequences. Importantly, one B.1.411 genome had the E484K
mutation while four sequences from had acquired N439K in
the spike protein along with the other B.1.411 lineage defining
mutations. Also, we observed that the 1H69/V70 deletion in the
spike had co-occurred in three of those with the N439Kmutation.
The other mutations seen in B.1.411 lineage are, T116I in NSP2,
L37F in NSP6, P323L, and M666I in NSP12 and T205I in the N
protein (Supplementary Table 2).
Outbreak With the B.1.1.7 Lineage
Twenty seven infections sampled between January and lateMarch
2021 belonged to the B.1.1.7 lineage. The first case of these was
an imported infection on the January 02, 2021, with a further 26
imported cases detected between January andMarch 2021. Except
one case infection that was seen in the community and another
infection seen in a fisherman in March 2021, all other cases
were identified within quarantine facilities during this period
(Figure 2). After a gradual decline in the number of cases by
the end of March, a rapid surge in the number of cases were
seen since mid-April 2021. From the 78 samples sequenced from
March 26 to April 30, 66 were found to be of the B.1.1.7 variant
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FIGURE 4 | Bayesian time-scale phylogeny of Sri Lankan samples. Tips are coloured by the sample location, and the external layer on the right shows the sample
lineages. The molecular clock was inferred using BEAST with HKY evolution model and a relaxed molecular clock (initial evolutionary rate was set to 0.001
substitutions/site/year). See Supplementary Figure 1 for the Bayesian tree with all posterior support values.
(Figures 2, 3). By the end of April, B.1.1.7 was the predominant
variant circulating in many parts of the country (Figure 5).
Other Severe Acute Respiratory
Syndrome Coronavirus-2 Variants
Detected
Twenty infections sampled from the community and quarantine
centres were classified into United Kingdom dominant B.1.258
(n = 7), Danish lineage B.1.428 (n = 5) and B.1.351 lineage, first
described in South Africa (n = 4). The rest of the sequences
identified were B.1.1.25 (n = 1), B.1.1.365 (n = 1), B.1.525
(n = 1), and B.1.617.2 (n = 1). Both variants of concern
(B.1.617.2 and B.1.351) were reported from returnees from India
and Middle East.
DISCUSSION
We report the first description of SARS-CoV-2 molecular
epidemiology in Sri Lanka from March 2020 to April 30,
2021. The virus strains identified in March 2020 belonged
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FIGURE 5 | Geographical distribution of SARS-CoV-2 B.1.411 and B.1.17 lineage infections in Sri Lanka sampled from October 2020 to April 2021. Radius of each
bubble accounts for the number of sequences reported from its representing district and the colour code based on the location is adopted from the Figure 4.
Colombo district is expanded in the middle to visualize its suburbs.
to clades B.1, B.2, B 1.1, and B.4, demonstrating that SARS-
CoV-2 strains were introduced to Sri Lanka from multiple
locations (Rambaut et al., 2020). Sri Lanka underwent a national
lockdown very early in the pandemic on the March 20, 2020,
when only 66 patients with SARS-CoV-2 were confirmed. This
lockdown, which continued until mid-May, managed to contain
the outbreak and prevent community transmission, except within
isolated community clusters. A further contained outbreak
occurred in mid-July within a DRC. Sequencing of a limited
number of these samples showed that this outbreak was due
to viruses belonging to lineage B.1 but which were distinct to
the former B.1 samples. The outbreak in the DRC was also
subsequently controlled and Sri Lanka did not report any cases
of locally acquired infection during the months of August and
September. Small numbers of reported cases were from imported
infections only.
A large outbreak was discovered in early October after a
clothing factory employee presented with pneumonia caused by
SARS-CoV-2, which was followed by the emergence of a large
second wave. We report that these were due to a lineage first
detected in Sri Lanka, B.1.411, that dispersed throughout the
country. The molecular clock analysis revealed that this lineage
most likely emerged in mid-late June 2020 and therefore, it is
possible that the virus was circulating in the community for
several months before leading to the large outbreak that started
in October. This highlights the potential for cryptic community
transmission leading to a national epidemic wave even in the face
of strict quarantine rules for returning travellers.
The B.1.411 Sri Lankan lineage has a unique spike mutation
H1159Y in the C terminal region, which was seen in 215/231
viruses belonging to this lineage. The significance of this
mutation is unknown. Also, the P323L mutation in NSP12
region, which is known to have co-evolved with D614Gmutation
was seen in 201/231 of the B.1.411 genomes (Kannan et al.,
2020). Even though there is no direct correlation between P323L
mutation and infectivity, given the fact that this mutation is
widespread and almost 100% co-existent with D614G, some
argue that this mutation could contribute to the enhanced viral
replication and infectivity seen in D614G dominant strains
(Kannan et al., 2020).
Most importantly, number of B.1.411 genomes carrying the
E484K (n = 1) and N439K (n = 4) mutations in the spike
protein were detected from both community and quarantine
centres between January to mid-February 2021, demonstrating
the potential for this lineage to evolve mutations that may
evade antibody responses. Even though E484K mutation is
predominantly seen in B.1.351 and P.1 lineages, recent evidence
indicates introduction of this mutation into other lineages such as
B.1.1.7 and B.1.243 (Wise, 2021). N439Kmutation in the receptor
bindingmotif (RBM) of the spike protein is known to enhance the
binding affinity of the spike protein to human ACE2 receptor and
increase the resistance against several neutralizing monoclonal
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antibodies (Thomson et al., 2021). In addition, three of those
genomes showed the S:H69/V70mutation, which often co-occurs
in the RBM with amino acid replacements such as N439K. This
also is shown to associate with increased infectivity (Kemp et al.,
2021). None of these were identified within the community. The
other more frequent mutations were T166I in NSP2, L37F in
NSP6, and T205I in N-protein. The L37F mutation in NSP6 is
thought to render the NSP6 protein less stable and therefore,
compromise the function of NSP6 (Wang et al., 2020). The other
mutations have been frequently reported in many other SARS-
CoV-2 lineages (Kaushal et al., 2020) while the other changes that
were detected in the amino acids have not been associated with
increased or reduced virulence.
Since the emergence of the “second wave” of SARS-CoV-2
infections in early October 2020, all repatriation from overseas
was stopped for a few months and subsequently, restarted in
December 2020. Along with this, viruses of many lineages were
identified within the quarantine centres where overseas returnees
were housed. Importantly, the B.1.1.7 variant, which has been
associated with higher transmissibility (Volz et al., 2021b) was
initially identified within these quarantine centres, but later from
the community from samples sequenced from April 2021. The
introduction and spread of the B.1.1.7 led to an exponential rise in
the number of cases, along with the number of deaths (Ministry of
Health, 2021c). Despite strict quarantine for returning travellers,
where several imported B.1.1.7 cases were detected, a period of
relative quiescence has been followed by an explosive increase
in cases across the country. During a period of 1 month, it
appears that the B.1.1.7 lineage had almost completely replaced
the circulating B.1.411 due to is higher transmissibility (Volz
et al., 2021b). The introduction of B.1.1.7 has also resulted in
higher case fatality rates (CFRs). For instance, the COVID-19
until to March 31 was 0.63%, whereas since the April 1 the CFRs
has risen to 0.89%, and is 1.09% during May 15–21 (Ministry of
Health, 2021c). The rise in the CFRs could be due to increase in
the number of patients requiring health care or possibly due to
the increase in viral virulence (Davies et al., 2021).
In summary, the viruses identified in March 2020, could be
due to multiple introductions from overseas. The large outbreak
that started in early October, appears to be due to spread of a
single virus lineage, B.1.411 until to end of March 2021. The
current exponential rise in case numbers appears to be due to the
introduction of B.1.1.7 into the community, rapidly displacing
the previous circulating B.1.411. As SARS-CoV-2 vaccine rollout
commences in Sri Lanka, ongoing genomic surveillance for
variants of concern will be vital.
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